Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ERBB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C3orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BTBD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFCP2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL11RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NNT-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on